Pilot study on basophil activation induced by contrast medium

Fundamental and Clinical Pharmacology

Volumn 25, Issue 2, 2011, Pages 267-276

  Böhm, Ingrid ^a,b   Speck, Ulrich ^c   Schild, Hans H ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Basophil granulocytes; Contrast medium; Degranulation; Immediate hypersensitivity

Indexed keywords

CD63 ANTIGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HISTAMINE; INTERLEUKIN 1BETA; IOPROMIDE; IOTROLAN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BASOPHIL DEGRANULATION; CELL ACTIVATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMEDIATE TYPE HYPERSENSITIVITY; MALE; PILOT STUDY; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, CD; BASOPHILS; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HISTAMINE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-3; IOHEXOL; MALE; MIDDLE AGED; PILOT PROJECTS; PLATELET MEMBRANE GLYCOPROTEINS; TOMOGRAPHY, X-RAY COMPUTED; TRIIODOBENZOIC ACIDS;

EID: 79952371626     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00826.x     Document Type: Article

References (40)

1. Cochran S.T., Bomyea K., Sayre J.W. Trends in adverse events after i.v. administration of contrast media. Am J Roentgenol (2001) 176 1385-1388.
2. No authors listed. Delayed allergy-like reactions to X-ray contrast media. Eur. Radiol. (1996) 6 (5 Suppl) 1-24.
3. Stellato C., Adkinson N.F. Jr Pathophysiology of contrast media anaphylactoid reactions: new perspectives on an old problem. Allergy (1998) 53 1111-1113.
4. Kanny G., Maria Y., Mentre B., Moneret-Vautrin D.A. Case report: recurrent anaphylactic shock to radiographic contrast media. Evidence supporting an exceptional IgE-mediated reaction. Allerg Immunol (Paris) (1993) 25 425-430.
5. Morcos S.K., Thomsen H.S. Adverse reactions to iodinated contrast media. Eur. Radiol. (2001) 11 1267-1275.
6. Schild H.H., Kuhl C.K., Hübner-Steiner U., Böhm I., Speck U. Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled trial. Radiology (2006) 240 56-64.
7. Böhm I., Schild H.H. A practical guide to diagnose lesser-known immediate and delayed contrast media-induced adverse cutaneous reactions. Eur. Radiol. (2006) 16 1570-1579.
8. Böhm I., Schild H. Contrast-media-induced hypersensitivity or allergic/allergic-like reactions? Suggestion for a more appropriate use of the nomenclature. Eur. J. Clin. Pharmacol. (2008) 64 931-932.
9. Coors E.A., Böhm I. Histamine-dependent and independent hypersensitivity reactions to contrast media: the impact of antihistamines. Antiinflamm Antiallergy Agents Med Chem (2006) 5 99-104.
10. Guéant-Rodriguez R.M., Romano A., Barbaud A., Brockow K., Guéant J.L. Hypersensitivity reactions to iodinated contrast media. Curr. Pharm. Des. (2006) 12 3359-3372.
11. Idée J.M., Pinès E., Prigent P., Corot C. Allergy-like reactions to iodinated contrast agents. A critical analysis. Fundam. Clin. Pharmacol. (2005) 19 263-281.
12. Morcos S.K. Review article: acute serious and fatal reactions to contrast media: our current understanding. Br. J. Radiol. (2005) 78 686-693.
13. Brockow K. Contrast media hypersensitivity--scope of the problem. Toxicology (2005) 209 189-192.
14. Brockow K., Christiansen C., Kanny G. et al. Management of hypersensitivity reactions to iodinated contrast media. Allergy (2005) 60 150-158.
15. Amon E.U., Ennis M., Lorenz W., Schnabel M., Schneider C. Histamine release induced by radiographic contrast media. Comparison between pulmonary and peritoneal mast cells derived from normotensive and spontaneously hypertensive rats. Int. Arch. Allergy Appl. Immunol. (1990) 92 203-208.
16. Ennis M., Lorenz W., Nehring E., Schneider C. In vitro and in vivo studies of radiographic contrast media-induced histamine release in pigs. Agents Actions (1991) 33 26-29.
17. Genovese A., Stellato C., Marsella C.V., Adt M., Marone G. Role of mast cells, basophils and their mediators in adverse reactions to general anesthetics and radiocontrast media. Int. Arch. Allergy Immunol. (1996) 110 13-22.
18. Peachell P.T., Morcos S.K. Effect of radiographic contrast media on histamine release from human mast cells and basophils. Br. J. Radiol. (1998) 71 24-30.
19. Rodriguez R.M., Gueant J.L., Aimone-Gastin I. et al. The increased histamine release in ischaemic heart disease patients undergoing coronaroangiography is not mediated by specific IgE. Allergy (2002) 72 61-66.
20. Rodriguez R.M., Gueant J.L., Gastin I.A. et al. Comparison of effects of ioxaglate versus iomeprol on histamine and tryptase release in patients with ischemic cardiomyopathy. Am. J. Cardiol. (2001) 88 185-188. A6.
21. Stellato C., de Crescenzo G., Patella V., Mastronardi P., Mazzarella B., Marone G. Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator release. J. Allergy Clin. Immunol. (1996) 97 838-850.
22. Vik H., Froysa A., Sonstevold A., Toft K., Stov P.S., Ege T. Complement activation and histamine release following administration of roentgen contrast media. Acta Radiol. Suppl. (1995) 399 83-89.
23. Böhm I., Speck U., Schild H. A possible role for cysteinyl-leukotrienes in non-ionic contrast media induced adverse reactions. Eur. J. Radiol. (2005) 55 431-436.
24. Eloy R., Corot C., Belleville J. Contrast media for angiography. Physicochemical properties, pharmacokinetics and biocompatibility. Clin Mater (1991) 7 89-197.
25. Laroche D., Aimone-Gastin I., Dubois F. et al. Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology (1998) 209 183-190.
26. Boumiza R., Debard A.L., Monneret G. The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy (2005) 3 9.
27. Benveniste J. The human basophil degranulation test as an in vitro method of diagnosis of allergies. Clin Allergy (1981) 11 1-11.
28. Moneret-Vautrin D.A., Sainte-Laudy J., Kanny G., Fremont S. Human basophil activation measured by CD63 expression and LTC4 release in IgE-mediated food allergy. Ann. Allergy Asthma Immunol. (1999) 82 33-40.
29. Ocmant A., Peignois Y., Mulier S., Hanssens L., Michils A., Schandené L. Flow cytometry for basophil activation markers: the measurement of CD203c up-regulation is as reliable as CD63 expression in the diagnosis of cat allergy. J. Immunol. Methods (2007) 320 40-48.
30. Monneret G., Gutowski M.C., Bienvenu J. Detection of allergen-induced basophil activation by expression of CD63 antigen using a tricolour flow cytometric method. Clin. Exp. Immunol. (1999) 115 393-396.
31. Sturm G.J., Bohm E., Trummer M., Weiglhofer I., Heinemann A., Aberer W. The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study. Allergy (2004) 59 1110-1117.
32. Pâris-Köhler A., Demoly P., Persi L., Lebel B., Bousquet J., Arnoux B. In vitro diagnosis of cypress pollen allergy by using cytofluorimetric analysis of basophils (Basotest). J. Allergy Clin. Immunol. (2000) 105 339-345.
33. Chirumbolo S., Vella A., Ortolani R. et al. Differential response of human basophil activation markers: a multi-parameter flow cytometry approach. Clin Mol Allergy (2008) 6 12.
34. Hartmann K., Beiglbock F., Czarnetzki B.M., Zuberbier T. Effect of CC chemokines on mediator release from human skin mast cells and basophils. Int. Arch. Allergy Immunol. (1995) 108 224-230.
35. Morita Y., Goto M., Miyamoto T. Effect of interleukin 2 on basophil histamine release. Allergy (1987) 42 104-108.
36. Subramanian N., Bray M.A. Interleukin 1 releases histamine from human basophils and mast cells in vitro. J. Immunol. (1987) 138 271-275.
37. Massey W.A., Randall T.C., Kagey-Sobotka A. et al. Recombinant human IL-1 alpha and -1 beta potentiate IgE-mediated histamine release from human basophils. J. Immunol. (1989) 143 1875-1880.
38. Haak-Frendscho M., Dinarello C., Kaplan A.P. Recombinant human interleukin-1 beta causes histamine release from human basophils. J. Allergy Clin. Immunol. (1988) 82 218-223.
39. Shimokawa H., Ito A., Fukumoto Y. et al. Chronic treatment with interleukin-1β induces coronary intimal lesions and vasospastic responses in pigs in vivo: the role of platelet-derived growth factor. J. Clin. Invest. (1996) 97 769-776.
40. Ito A., Shimokawa H., Kadokami T. et al. Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1β in pigs in vivo. J. Clin. Invest. (1995) 96 1288-1294.